Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis

Rheumatology

Volumn 50, Issue 4, 2011, Pages 776-780

  Priori, Roberta ^a   Barone, Francesca ^b   Alessandri, Cristiano ^a   Colafrancesco, Serena ^a   McInnes, Iain B ^c   Pitzalis, Costantino ^d   Valesini, Guido ^a   Bombardieri, Michele ^d  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Adult onset Still's disease; Hepatitis; IL 18; Liver

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CD68 ANTIGEN; FERRITIN; INTERLEUKIN 18;

ADULT; ADULT ONSET STILL DISEASE; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MALE; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANTIBODIES; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; ASPARTATE AMINOTRANSFERASES; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; FEMALE; HEPATITIS; HUMANS; INTERLEUKIN-18; ITALY; LIVER; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; STILL'S DISEASE, ADULT-ONSET; YOUNG ADULT;

EID: 79952781481     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq397     Document Type: Article

References (18)

1. Efthimiou P, Paik PK, Bielory L. Diagnosis and management of adult onset Still's disease. Ann Rheum Dis 2006;65:564-72.
2. Ogata A, Kitano M, Yamanaka J et al. Interleukin 18 and hepatocyte growth factor in fulminant hepatic failure of adult onset Still's disease. J Rheumatol 2003;30:1093-6.
3. Chen DY, Lan JL, Lin FJ, Hsieh TY, Wen MC. Predominance of Th1 cytokine in peripheral blood and pathological tissues of patients with active untreated adult onset Still's disease. Ann Rheum Dis 2004;63:1300-6.
4. Bombardieri M, McInnes IB, Pitzalis C. Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions. Expert Opin Biol Ther 2007;7: 31-40.
5. Yamaguchi M, Ohta A, Tsunematsu T et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19:424-30.
6. Conigliaro P, Priori R, Bombardieri M et al. Lymph node IL-18 expression in adult-onset Still's disease. Ann Rheum Dis 2009;68:442-3.
7. Pouchot J, Sampalis JS, Beaudet F et al. Adult Still's disease: manifestations, disease course, and outcome in 62 patients. Medicine 1991;70:118-36.
8. Boraschi D, Dinarello CA. IL-18 in autoimmunity: review. Eur Cytokine Netw 2006;17:224-52.
9. Choi JH, Suh CH, Lee YM et al. Serum cytokine profiles in patients with adult onset Still's disease. J Rheumatol 2003;30:2422-7.
10. Kawashima M, Yamamura M, Taniai M et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. Arthritis Rheum 2001;44:550-60.
11. Andrè s E, Kurtz JE, Perrin AE et al. Retrospective monocentric study of 17 patients with adult Still's disease, with special focus on liver abnormalities. Hepatogastroenterology 2003;50:192-5.
12. Yumoto E, Higashi T, Nouso K et al. Serum gamma-interferon-inducing factor (IL-18) and IL-10 levels in patients with acute hepatitis and fulminant hepatic failure. J Gastroenterol Hepatol 2002;17:285-94.
13. Sakao Y, Takeda K, Tsutsui H et al. IL-18-deficient mice are resistant to endotoxin-induced liver injury but highly susceptible to endotoxin shock. Int Immunol 1999;11: 471-80.
14. Tsutsui H, Matsui K, Okamura H, Nakanishi K. Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol Rev 2000;174:192-209.
15. Munder M, Mallo M, Eichmann K et al. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J Exp Med 1998;187:2103-8.
16. Dao T, Mehal WZ, Cripe IN. IL-18 augments perforin-dependent cytotoxicity of liver NK-T cells. J Immunol 1998;161:2217-22.
17. Finotto S, Siebler J, Hausding M et al. Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo. Gut 2004;53:392-400.
18. Tsutsui H, Matsui K, Kawada N et al. IL-18 accounts for both TNF-alpha- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice. J Immunol 1997;159:3961-7.